|
Transfusion-free interval is associated with improved survival in patients with higher-risk myelodysplastic syndromes engaged in routine care
|
Jun 2018
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
The Myelodysplastic Syndromes (MDS): A personal recollection of four decades of classification and prognostic scoring systems.
|
Apr 2013
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
Treatment sequence of lenalidomide and hypomethylating agents and the impact on clinical outcomes for patients with myelodysplastic syndromes.
|
Jan 2019
|
Leuk Lymphoma.
|
myelodysplastic syndromes (MDS)
|
|
Improving the diagnosis and treatment of patients with myelodysplastic syndromes through a performance improvement initiative
|
Jan 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
MicroRNA-194-5p could serve as a diagnostic and prognostic biomarker in myelodysplastic syndromes
|
Apr 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
A systematic review of patient reported outcomes in phase II or III clinical trials of myelodysplastic syndromes and acute myeloid leukemia
|
Jun 2018
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: results of a bone marrow failure consortium study.
|
Mar 2012
|
Leuk Res
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
microRNAs in myelodysplastic syndromes: How much do we know and not know?
|
Mar 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
Effectiveness and safety of different azacitidine dosage regimens in patients with myelodysplastic syndromes or acute myeloid leukemia
|
Mar 2014
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes
|
Jan 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
